Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Kezar Life Sciences, Inc. (KZR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Gifted 3,500,000 shares
@ $0 |
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| Garner Elizabeth (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| Wallace Courtney (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| Klearman Micki (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 02/07/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 25,000 shares
@ $7.146, valued at
$178.7k
Sold 40,000 shares
@ $6.883, valued at
$275.3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 50,000 shares
@ $6.85, valued at
$342.5k
|
|
| 01/25/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 80,000 shares
@ $6.81, valued at
$544.8k
Sold 80,000 shares
@ $6.98, valued at
$558.4k
|
|
| 01/19/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 6,114 shares
@ $6.79, valued at
$41.5k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Mordwinkin Nicholas Michael (Chief Business Officer) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 185,000 options to buy
@ $6.84, valued at
$1.3M
|
|
| 01/10/2023 |
4
| Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 190,000 options to buy
@ $6.84, valued at
$1.3M
|
|
| 01/10/2023 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 195,000 options to buy
@ $6.84, valued at
$1.3M
|
|
| 01/10/2023 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 580,000 options to buy
@ $6.84, valued at
$4M
|
|
| 01/10/2023 |
4
| Henig Noreen (Chief Medical Officer) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 220,000 options to buy
@ $6.84, valued at
$1.5M
|
|
| 01/09/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 12,162 shares
@ $6.97, valued at
$84.8k
Sold 3,000 shares
@ $6.89, valued at
$20.7k
|
|
| 01/05/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 25,000 shares
@ $7.1, valued at
$177.5k
Sold 500 shares
@ $7.1, valued at
$3.6k
Sold 30,000 shares
@ $7.17, valued at
$215.1k
|
|
| 11/14/2022 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Exercised 27,000 options to buy
@ $0.9, valued at
$24.3k
|
|
|
|
|